Founder since 1999

Partner/Owner since 1999

Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet becker and associes
operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

Philippe Becker has worked on the following 70 EPO patent applications which have been published in the last five years:

EP11743497

COMPOSITIONS FOR TREATING HEARTWORM INFESTATION

IPC classification:
A61K 9/00, A61K 31/7048, A61K 45/06, A61P 33/10
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP11740661

PLANTS RESISTANT TO PATHOGENS AND METHODS FOR PRODUCTION THEREOF

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Genoplante Valor SAS
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11761355

PLANTS RESISTANT TO FUNGAL PATHOGENS AND METHODS FOR PRODUCTION THEREOF

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Genoplante Valor SAS
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP11782584

LACCASES AND USES THEREOF

IPC classification:
C12N 5/00, C12N 9/02, C12N 15/00
Applicant:
Deinove SA
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12710730

DOMINANT NEGATIVE HSP110 MUTANT AND ITS USE IN PROGNOSING AND TREATING CANCERS

IPC classification:
C07D 207/00, C07K 14/47, C12Q 1/68, G01N 33/50
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bourgogne Dijon
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Bertrand Domenego, Cabinet Lavoix
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12730659

BIOMOLECULAR ELECTRONIC DEVICE AND PROCESS OF USE

IPC classification:
C07K 14/415, C07K 14/47, G01N 27/00, G01N 33/487
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP13196461

Baclofen and acamprosate based therapy of neurological disorders

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/145, A61K 31/164, A61K 31/185, A61K 31/195, A61K 31/197, A61K 31/42, A61K 31/44, A61K 31/445, A61K 31/64, A61K 45/06, A61P 25/28
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12306354

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

IPC classification:
A61K 31/122, A61K 31/137, A61K 31/138, A61K 31/16, A61K 31/197, A61K 31/216, A61K 31/4164, A61K 31/42, A61K 31/437, A61K 31/44, A61K 31/445, A61K 31/495, A61K 31/519, A61K 31/53, A61K 31/55, A61K 31/7004, A61P 5/48
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306428

Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone

IPC classification:
A01K 67/02, A61K 38/24
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306459

Hair growth compositions and methods

IPC classification:
A61K 8/41, A61K 8/44, A61K 8/49, A61K 8/64, A61P 17/14, A61Q 7/00, A61Q 7/02, C07K 16/18
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306548

Triazine formulations with a second active ingredient and surfactant(s)

IPC classification:
A61K 9/10, A61K 31/53, A61K 45/06, A61K 47/14, A61K 47/24, A61K 47/34, A61P 33/02
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306546

New treatments with triazines

IPC classification:
A61K 9/08, A61K 9/10, A61K 31/53, A61K 33/26, A61P 33/02
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306547

Treatment of Coccidiosis with intramuscular triazine composition

IPC classification:
A61K 9/08, A61K 9/10, A61K 31/53, A61K 33/26, A61P 33/02
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12751536

SYNTHETIC CAPSID PROTEINS AND USES THEREOF

IPC classification:
A61K 39/12, C07K 14/01
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12305153

Method of preventing allergies

IPC classification:
A61K 39/35
Applicant:
DBV Technologies SA
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12850374

DEVICE, USE THEREOF AND METHOD FOR REDUCING SCARRING OF WOUND

IPC classification:
A61B 17/08, A61F 13/02, A61F 15/00
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13163299

Fusion polypeptides and vaccines

IPC classification:
A61K 39/12, A61K 39/385
Applicant:
CEVA Santé Animale SA
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13196468

Baclofen and acamprosate based therapy of neurological disorders

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/42, A61K 31/64, A61P 25/00, A61P 25/16, A61P 25/28
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13305592

TAFA4 compounds and uses thereof for treating pain

IPC classification:
A61K 38/17
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733645

HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE

IPC classification:
A61K 31/397, A61K 31/40, A61K 31/4025, A61K 31/404, A61P 25/00, A61P 29/00, A61P 35/00, C07D 205/04, C07D 207/16, C07D 207/22, C07D 209/18, C07D 209/42, C07D 209/94, C07D 403/04, C07D 471/04, C07D 471/10, C07D 487/04, C07D 487/10, C07D 498/10
Applicant:
Novartis AG
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Michael Stierwald, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13741412

HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE

IPC classification:
A61K 31/4355, A61K 31/436, A61K 31/4365, A61K 31/437, A61K 31/4375, A61K 31/519, A61P 25/02, A61P 25/04, A61P 35/00, C07D 211/60, C07D 211/66, C07D 471/04, C07D 491/048, C07D 491/056, C07D 495/04
Applicant:
Novartis AG
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13741446

HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE

IPC classification:
A61K 31/496, A61K 31/4985, A61K 31/551, A61P 25/02, A61P 25/04, A61P 35/00, C07D 241/04, C07D 243/08, C07D 403/04, C07D 413/04, C07D 413/06, C07D 487/04
Applicant:
Novartis AG
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13170932

Compositions and Method for controlling infections in non-human mammals using acute phase proteins

IPC classification:
A61K 9/00, A61K 38/17, A61K 38/44, A61K 38/57, A61P 15/14, A61P 31/04
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14156048

New therapeutic approaches for treating neuroinflammatory conditions

IPC classification:
A61K 31/137, A61K 31/4365, A61K 45/06, A61P 25/28
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP13702074

METHOD OF PREVENTING ALLERGIES

IPC classification:
A61K 39/35
Applicant:
DBV Technologies SA
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13172069

Methods for detecting an infectious agent, in particular HIV1, using long noncoding RNA

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Université Montpellier 2 Sciences et Techniques
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12193489

Mitral valve replacement system

IPC classification:
A61F 2/24
Agent:
Hepp Wenger Ryffel AG
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP11306094

Synthetic capsid proteins and uses thereof

IPC classification:
A61K 39/12, C07K 14/01
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13706549

NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/42, A61K 31/64, A61P 25/16
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13706548

NEW COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/42, A61K 31/44, A61P 25/00, A61P 29/00
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP14176796

New compositions for treating CMT and related disorders

IPC classification:
A61K 31/192, A61K 31/197, A61K 31/4164, A61K 31/4178, A61K 31/436, A61K 31/485, A61K 31/575, A61K 31/7004, A61K 45/06, A61P 25/14, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13709456

METHODS FOR DETERMINING THE TROPISM AND RECEPTOR USAGE OF A VIRUS, IN PARTICULAR HIV, IN BODY SAMPLES TAKEN FROM THE CIRCULATION

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Université Montpellier 2 Sciences et Techniques
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP13713195

MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES

IPC classification:
A61K 39/12, A61K 39/17, C12N 15/869
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12802212

METHOD FOR SCREENING SUBSTANCES HAVING BODY-WEIGHT-REGULATING EFFECT

IPC classification:
C12Q 1/02, C12Q 1/68, G01N 33/50
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP13781879

TRUE-SPECTROSCOPIC DUAL MODE HIGH RESOLUTION FULL-FIELD OPTICAL COHERENCE TOMOGRAPHY USING LIQUID CRYSTAL DEVICES

IPC classification:
G01B 9/02, G01N 21/21
Applicant:
Ben Gurion University of The Negev Research and Development Authority
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13183393

Recombinant Marek's disease viruses and uses thereof

IPC classification:
A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/17, C12N 5/10, C12N 15/86
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306062

Combinations of nootropic agents for treating cognitive dysfunctions

IPC classification:
A61K 31/135, A61K 31/137, A61K 31/185, A61K 31/195, A61K 31/44, A61K 31/635, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/36, A61P 39/02, A61P 43/00
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306064

Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesis

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/197, A61K 31/20, A61K 31/222, A61K 31/4015, A61K 31/4166, A61K 31/4192, A61K 31/515, A61K 31/53, A61K 31/55, A61K 31/5513, A61K 31/635, A61K 31/64, A61K 31/7048, A61P 25/08
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306063

Therapeutic approaches for treating parkinson's disease

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/155, A61K 31/185, A61K 31/192, A61K 31/197, A61K 31/198, A61K 31/24, A61K 31/403, A61K 31/4164, A61K 31/42, A61K 31/421, A61K 31/4402, A61K 31/4422, A61K 31/445, A61K 31/506, A61K 31/519
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13780585

CO2 CAPTURE WITH CARBONIC ANHYDRASE AND TERTIARY AMINO SOLVENTS FOR ENHANCED FLUX RATIO

IPC classification:
B01D 53/14, B01D 53/62
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306471

Phage therapy of pseudomonas infections

IPC classification:
A61K 35/76, C07K 14/005, C12N 7/00, C12N 15/33
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306498

Double sheet aluminum panel and method for manufacture thereof

IPC classification:
B32B 7/12, B32B 15/01, B32B 15/20, B32B 37/12, E04B 1/94, E04F 13/12
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13737622

BACLOFEN AND ACAMPROSATE BASED THERAPY OF MACULAR DEGENERATION DISORDERS

IPC classification:
A61K 31/185, A61K 31/197, A61P 27/02
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP13192762

Novel uses of veterinary compositions for anti-parasitic treatment

IPC classification:
A01N 25/00, A01N 43/40, A01N 51/00, A61K 9/00
Applicant:
Ceva Animal Health
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13306841

Novel veterinary isometamidium compositions and similar substances and uses thereof

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/473, A61K 47/02, A61P 33/02, C07D 221/12
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13779749

THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS

IPC classification:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/197, A61K 31/20, A61K 31/222, A61K 31/4015, A61K 31/4166, A61K 31/4192, A61K 31/515, A61K 31/53, A61K 31/55, A61K 31/635, A61K 31/64
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13759490

NOOTROPIC COMPOSITIONS FOR IMPROVING MEMORY PERFORMANCE

IPC classification:
A61K 31/135, A61K 31/137, A61K 31/185, A61K 31/195, A61K 31/44, A61K 31/635, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/36, A61P 39/02, A61P 43/00
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP14305041

Phage Therapy of E coli infections

IPC classification:
A61K 35/76, C07K 14/005, C12N 7/00, C12Q 1/70, G01N 33/569
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14305074

ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF

IPC classification:
A61K 47/48, A61P 25/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14305100

Resistance to gravepine fanleaf virus

IPC classification:
A01H 5/08, C12N 15/82
Applicant:
Vrije Universiteit Brussel
Applicant:
Institut National de la Recherche Agronomique (INRA)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12885897

LEG CONTROL SYSTEM AND ENGINEERING MACHINE

IPC classification:
G05B 19/4155
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP10858290

ASSEMBLED DRILLING TOOL

IPC classification:
B28D 1/04, B28D 1/14, E21B 7/00, E21B 17/00, E21B 17/04, E21B 17/042, E21B 17/046
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11781777

STRESS-RESISTANT PLANTS AND THEIR PRODUCTION

IPC classification:
A01H 5/00, C07K 14/415, C12N 15/82
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Université Montpellier 2 Sciences et Techniques
Applicant:
Institut National de la Recherche Agronomique (INRA)
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12160350

THERAPEUTIC PIPERAZINES AS PDE4 INHIBITORS

IPC classification:
A61K 31/495, A61K 31/496, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/28, C07D 241/04, C07D 241/08, C07D 243/08, C07D 401/06, C07D 403/04, C07D 403/06, C07D 405/08
Agent:
Nicholas Kirkham, Graham Watt & Co LLP
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14754748

COMPOSITION FOR TREATING INFLAMMATORY BRAIN DISEASES WHICH INCLUDES STEM CELL AS ACTIVE INGREDIENT

IPC classification:
A61K 35/12, A61P 25/00, A61P 29/00
Applicant:
Samsung Life Public Welfare Foundation
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP14174599

Phospholipase for treatment of immunosuppression

IPC classification:
C07K 16/40, C12N 9/20
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14850829

A USE OF THE MIXTURE OF A SALT AND SUGAR IN THE MANUFACTURE OF A MEDICAMENT EMPLOYED FOR TREATING LAX VEGINA SYNDROME OR COLPOXEROSIS DISEASE IN A MAMMAL

IPC classification:
A61K 31/70, A61K 33/14, A61P 15/02
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP14814655

COMPOSITION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK, COMPRISING ADK PROTEIN AS ACTIVE INGREDIENT

IPC classification:
A61K 38/16, A61P 11/00, A61P 31/04
Applicant:
Konkuk University Glocal Industry-Academic Collaboration Foundation
Applicant:
Konkuk University Industrial Cooperation Corp.
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP14184663

Methods of prognosing and treating triple negative breast cancer

IPC classification:
C12Q 1/68
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11714559

METHOD OF VACCINATION

IPC classification:
A61K 39/00, A61K 39/29
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP14306788

Phage therapy

IPC classification:
A61K 35/76, C12N 7/00
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196650

New therapeutic approaches for treating CMT and related disorders

IPC classification:
A61K 9/20, A61K 31/197, A61K 31/485, A61K 31/7004, A61P 25/28
Applicant:
Pharnext
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP14198610

Compositions and methods for diagnosing thyroid cancer

IPC classification:
C12Q 1/68
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14307110

Recombinant swinepox virus and vaccines

IPC classification:
A61K 39/00, A61K 39/275, C12N 15/863
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15305102

Recombinant MDV1 and the uses thereof

IPC classification:
A61K 39/255
Applicant:
Ceva Sante Animale
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
APPLICATION PUBLISHED
EP11779582

NEW MARKER OF BREAST TUMORS FROM THE LUMINAL-B SYBTYPE

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Willy Barbot, SIMODORO
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180334

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180487

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180375

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12702017

COMBINATORIAL BIOMARKERS FOR CLINICAL APPLICATIONS IN LUNG CANCER PATIENT MANAGEMENT

IPC classification:
G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature